Purification and properties of cytochrome P-450 from homogenates of human fetal livers.

[1]  O. Pelkonen.  Differential inhibition of aryl hydrocarbon hydroxylase in human foetal liver, adrenal gland and placenta*. , 2009, Acta pharmacologica et toxicologica.

[2]  T. Kamataki,et al.  Postnatal development of constitutive forms of cytochrome P-450 in liver microsomes of male and female rats. , 1984, Biochemical pharmacology.

[3]  F. Guengerich,et al.  Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. , 1982, Biochemistry.

[4]  T. Boulikas,et al.  Silver staining of proteins in polyacrylamide gels. , 1981, Analytical biochemistry.

[5]  P. Thomas,et al.  Regulation of three forms of cytochrome P-450 and epoxide hydrolase in rat liver microsomes. Effects of age, sex, and induction. , 1981, The Journal of biological chemistry.

[6]  M. Juchau,et al.  Drug Metabolism by the Human Fetus , 1980, Clinical pharmacokinetics.

[7]  Kamataki Tetsuya,et al.  Purification and properties of cytochrome P-450 and NADPH-cytochrome c (P-450) reductase from human liver microsomes , 1979 .

[8]  Kamataki Tetsuya,et al.  Partial purification and properties of cytochrome P450 from homogenates of human fetal livers. , 1979 .

[9]  F. Guengerich.  Separation and purification of multiple forms of microsomal cytochrome P-450. Partial characterization of three apparently homogeneous cytochromes P-450 prepared from livers of phenobarbital- and 3-methylcholanthrene-treated rats. , 1978, The Journal of biological chemistry.

[10]  J. Depierre,et al.  Measurement of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin. , 1978, Analytical biochemistry.

[11]  A. Aitio.  A simple and sensitive assay of 7-ethoxycoumarin deethylation. , 1978, Analytical biochemistry.

[12]  F. Guengerich.  Separation and purification of multiple forms of microsomal cytochrome P-450. Activities of different forms of cytochrome P-450 towards several compounds of environmental interest. , 1977, The Journal of biological chemistry.

[13]  U. Muller-eberhard,et al.  Purification of the major cytochrome P-450 of liver microsomes from rabbits treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). , 1977, Biochemical and biophysical research communications.

[14]  P. Thomas,et al.  Properties of purified liver microsomal cytochrome P450 from rats treated with the polychlorinated biphenyl mixture Aroclor 1254. , 1977, Molecular pharmacology.

[15]  R. A. Neal,et al.  Studies of the metabolism of diethyl p-nitrophenyl phosphorothionate (parathion) and benzphetamine using an apparently homogeneous preparation of rat liver cytochrome P-450: effect of a cytochrome P-450 antibody preparation. , 1976, Molecular pharmacology.

[16]  A. Y. Lu,et al.  Separation, purification, and properties of multiple forms of cytochrome P-450 from the liver microsomes of phenobarbital-treated mice. , 1976, The Journal of biological chemistry.

[17]  R. Philpot,et al.  Separation and purification of two forms of hepatic cytochrome P-450 from untreated rabbits. , 1976, Molecular pharmacology.

[18]  Y. Imai,et al.  Purification of a substrate complex of cytochrome P-450 from liver microsomes of 3-methylcholanthrene-treated rabbits. , 1976, Biochemical and biophysical research communications.

[19]  M. J. Coon,et al.  Drug and fatty acid hydroxylation by solubilized human liver microsomal cytochrome P-450-phospholipid requirement. , 1975, Biochemical pharmacology.

[20]  Y. Imai,et al.  A gel-electrophoretically homogeneous preparation of cytochrome P-450 from liver microsomes of phenobarbital-pretreated rabbits. , 1974, Biochemical and biophysical research communications.

[21]  S. Orrenius,et al.  The presence of a monooxygenase system in human fetal liver microsomes. , 1970, Life sciences. Pt. 2: Biochemistry, general and molecular biology.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[23]  A. Conney.  Pharmacological implications of microsomal enzyme induction. , 1967, Pharmacological reviews.

[24]  A. Ito,et al.  Evidence for biochemically different types of vesicles in the hepatic microsomal fraction. , 1966, Journal of biochemistry.

[25]  T. Omura,et al.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE. , 1964, The Journal of biological chemistry.

[26]  A. H. Phillips,et al.  Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. , 1962, The Journal of biological chemistry.

[27]  T NASH,et al.  The colorimetric estimation of formaldehyde by means of the Hantzsch reaction. , 1953, The Biochemical journal.

[28]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[29]  F. Guengerich,et al.  Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver. , 1980, Archives of biochemistry and biophysics.

[30]  T. Kamataki,et al.  The involvement of cytochrome P-488 and P-450 in NADH-dependent O-demethylation of p-nitroanisole in rat liver microsomes. , 1979, Japanese journal of pharmacology.

[31]  M. Noshiro,et al.  Immunochemical study on the electron pathway from NADH to cytochrome P-450 of liver microsomes. , 1978, Journal of biochemistry.

[32]  H. Gelboin.  Carcinogens, enzyme induction, and gene action. , 1967, Advances in cancer research.

[33]  J. Gillette.  Biochemistry of drug oxidation and reduction by enzymes in hepatic endoplasmic reticulum. , 1966, Advances in pharmacology.